Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HR-pQCT Study in Postmenopausal Women Previously Treated With Denosumab
NCT00890981Phase 3Completed
- Sponsor
- Amgen
- Start
- Jul 2009
- Primary completion
- Jun 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 3 trial of denosumab in postmenopausal osteoporosis, sponsored by Amgen. Started Jul 2009; status: completed.
02
Drugs
denosumab
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00890981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00890981.